Biotech stocks saw notable upward momentum in Thursday's after-hours trading session, with several names posting strong percentage gains despite the absence of fresh company-specific developments.
Coherus Oncology, Inc. (CHRS) climbed 9.09% to close at $1.73, adding $0.14 in extended trading.
Sensei Biotherapeutics, Inc. (SNSE) surged 10.06% after hours, finishing at $12.47 with a gain of $1.14.
Cue Biopharma, Inc. (CUE) advanced 9.37% to $0.40, rising $0.034 in after-hours action.
Alpha Tau Medical Ltd. (DRTS) added 3.35% to $7.41, up $0.24. While there was no news Thursday, the company was recently in focus after Taiho Oncology announced on January 20 that Peter Melnyk had joined as President and Chief Operating Officer.
Cingulate Inc. (CING) edged higher by 1.49%, closing at $5.45 after hours with a gain of $0.08.
uniQure N.V. (QURE) posted a strong 9.96% jump to $24.95, adding $2.26 in extended trading.
IO Biotech, Inc. (IOBT) gained 4.19% to $0.50, up $0.020 after hours. While Thursday brought no fresh news, the company recently announced on January 21 that it is exploring a range of strategic alternatives, including potential mergers, asset sales, or even liquidation, alongside cost-cutting measures such as workforce reductions.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.